Hussman Strategic Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-28,800
Closed -$1.08M 372
2021
Q1
$1.08M Sell
28,800
-53,200
-65% -$1.66M 0.22% 174
2020
Q4
$2.22M Sell
82,000
-71,000
-46% -$1.83M 0.58% 57
2020
Q3
$3.84M Buy
153,000
+28,000
+22% +$408K 1.02% 10
2020
Q2
$952K Buy
+125,000
New +$915K 0.24% 164
2015
Q4
Sell
-4,000
Closed -$128K 225
2015
Q3
$128K Buy
+4,000
New +$136K 0.02% 170
2014
Q4
Sell
-5,000
Closed -$164K 211
2014
Q3
$164K Hold
5,000
0.01% 178
2014
Q2
$170K Buy
+5,000
New +$171K 0.01% 163
2013
Q3
Sell
-3,500
Closed -$118K 229
2013
Q2
$118K Buy
+3,500
New +$116K 0.01% 211

Other funds holding ACH

Hussman Strategic Advisors's ACH Position: Q2 2021 in Review

Hussman Strategic Advisors sold out of Accendra Health (ACH) in Q2 2021, closing a stake of 28,800 shares — an estimated $1.08M sold.

Hussman Strategic Advisors first reported a position in ACH in Q2 2013 and held it in 8 quarters. The position peaked at $3.84M in Q3 2020. 260 funds tracked by Wall St. Rank hold ACH as of Q2 2021.

  • Hussman Strategic Advisors reported no remaining Accendra Health position as of Q2 2021 after selling out during the quarter.
  • Hussman Strategic Advisors sold 28,800 Accendra Health shares in Q2 2021, an estimated $1.08M.
  • Hussman Strategic Advisors first reported a position in Accendra Health in Q2 2013 and held it in 8 quarters.
  • Hussman Strategic Advisors's Accendra Health position peaked at $3.84M in Q3 2020.
  • 260 funds tracked by Wall St. Rank held Accendra Health as of Q2 2021.

Based on Hussman Strategic Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.